Description
Product Overview
GLOW Blend is a lyophilized peptide formulation composed of three high-purity synthetic analogs — GHK-Cu, TB-500, and BPC-157 — combined for controlled laboratory study. Each compound in this blend is supplied for in vitro research involving molecular structure, receptor interaction, and peptide stability under regulated conditions.
Chemical Composition
- GHK-Cu (50mg): Copper-binding tripeptide analog composed of glycine, histidine, and lysine, commonly used to study peptide–metal ion coordination and binding characteristics.
- TB-500 (10mg): Synthetic peptide fragment derived from thymosin beta-4, utilized for laboratory exploration of peptide-receptor interaction and cellular framework dynamics.
- BPC-157 (10mg): Stable pentadecapeptide sequence applied in in vitro environments for protein expression, peptide stability, and biochemical response studies.
Research Context
This formulation is designed to support peptide-based laboratory investigations, including research on peptide synergy, molecular bonding, and receptor-level communication. It enables researchers to study multi-peptide systems under controlled, sterile, and regulated experimental setups.
Specifications
- Unit Size: 70 mg per vial
- Form: Lyophilized powder
- Storage: Keep in a cool, dry environment away from direct light and moisture
Intended Use
For Research Use Only (RUO). This product is intended exclusively for scientific and laboratory research. It is not for human or veterinary use, nor for diagnostic, therapeutic, or cosmetic applications. Use is restricted to qualified professionals working in controlled research environments.
Disclaimer
GLOW Blend has not been reviewed or approved by the FDA or any regulatory authority. It is not intended to diagnose, treat, or prevent any disease. All information provided is for educational and informational purposes related to laboratory research. By purchasing this material, the buyer confirms they are a qualified researcher conducting lawful scientific investigation
